Cell rejuvenation with small molecules — no gene editing required. Starting with cancer, extending to longevity.
CellRep has raised $425K in total funding. The most recent round was Angel. The last funding was announced in May 2025.
CellRep's investors include Maximiliano Ojeda, GRID EXPONENTIAL, AIR Capital, Pedro Arnt, Ariel Arrieta.
CellRep is headquartered in Buenos Aires, Argentina.
Cell rejuvenation with small molecules — no gene editing required. Starting with cancer, extending to longevity.
CellRep is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CellRep — Funding & Investors." VCBacked, May 1, 2025, https://www.vcbacked.co/company/cellrep. Accessed November 14, 2026.
VCBacked. (2025). CellRep — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/cellrep
{{cite web |title=CellRep — Funding & Investors |url=https://www.vcbacked.co/company/cellrep |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at CellRep? Request a listing update